Skip to main content

European Asthma Research and Innovation Partnership

Objective

Europe has 30 million people with asthma, whose treatment costs about €20 bn annually. Productivity lost through poor asthma control in Europe is estimated to be €9.8 bn per year. By 2020 approximately 120,000 people in Europe will die from asthma attacks, and 4 million hospitalisations will be needed for the most severely affected.
The Objectives of EARIP (European Asthma Research and Innovation Partnership) include to:
• reduce the annual level of deaths by 25% within 10 years and 50% within 20 years, and hospitalisations by 50%
• identify more effective mechanisms to discover, develop and prioritise biological targets to helping pharmaceutical companies reduce asthma attacks and hospital admissions in asthma of varying severity and mechanistic sub-type
• develop new systems, models and tools for the phenotypic stratification of asthma, and determine priority needs of sub-groups
• identify innovations needed in health and care systems to put individual patients at the heart of asthma management/treatment, and improve outcomes with better diagnostic and patient self-management plans
• review research gaps in treatment of asthma identified at national and international levels, and rank in priority order
• identify and internationally ratify a list of research objectives of greatest potential added value in the treatment and management of asthma and produce a Roadmap setting out priorities for the research and innovations needed
• address the fragmentation of research approaches and healthcare systems in the management of asthma that has resulted in European countries being 14 of the world's worst 20 for prevalence of asthma in adults, and bring together European stakeholders who will together to address specific Objectives, and review how best to establish a European Innovation Partnership, its Vision, Strategic Priorities, Priority Actions, representative core membership, organisational and governance structure, and requirements for wider interactions

Field of science

  • /medical and health sciences/clinical medicine/pneumology/asthma
  • /social sciences/sociology/governance
  • /social sciences/economics and business/economics/production economics/productivity

Call for proposal

FP7-HEALTH-2013-INNOVATION-1
See other projects for this call

Funding Scheme

CSA-SA - Support actions

Coordinator

ASTHMA UK LBG
Address
18 Mansell Street
E1 8AA London
United Kingdom
Activity type
Other
EU contribution
€ 175 103
Administrative Contact
Harriet Jones (Ms.)

Participants (12)

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
United Kingdom
EU contribution
€ 55 212
Address
South Kensington Campus Exhibition Road
SW7 2AZ London
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Tatjana Palalic (Ms.)
KAROLINSKA INSTITUTET
Sweden
EU contribution
€ 40 000
Address
Nobels Vag 5
17177 Stockholm
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Per-Olof Larsson
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING
Belgium
EU contribution
€ 67 000
Address
Rue Du Congrès 35
1000 Brussels
Activity type
Other
Administrative Contact
Susanna Palkonen (Ms.)
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Participation ended

Netherlands
Address
Dr Molewaterplein 40
3015 GD Rotterdam
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Simone Vd Kuil (Ms.)
EUROPEAN LUNG FOUNDATION
United Kingdom
EU contribution
€ 34 000
Address
Glossop Road 442
S10 2PX Sheffield
Activity type
Other
Administrative Contact
Micah Royston Clayton
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Greece
EU contribution
€ 40 000
Address
6 Christou Lada Str
10561 Athina
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Efstathia Kafentzi (Mrs.)
UNIVERSITY OF SOUTHAMPTON
United Kingdom
EU contribution
€ 48 685
Address
Highfield
SO17 1BJ Southampton
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Yan Qiao (Ms.)
SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS
Switzerland
Address
Promenade 35
7270 Davos Platz
Activity type
Research Organisations
Administrative Contact
Heinz Walti
UNIVERSYTET MEDYCZNY W LODZI.
Poland
Address
Al. Kosciuszki, 4
90419 Lodz
Activity type
Higher or Secondary Education Establishments
Administrative Contact
Maciej Kupczyk (Dr.)
NOVARTIS PHARMA AG
Switzerland
Address
Lichtstrasse 35
4056 Basel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
Chris Compton (Dr.)
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
United Kingdom
Address
Great West Road 980
TW89GS Brentford
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Administrative Contact
David Myles (Dr.)
FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA
Spain
EU contribution
€ 40 000
Address
Calle Luis Fontes Pagan 9 Edif Emi Hospital Reina Sofia
30003 Murcia
Activity type
Research Organisations
Administrative Contact
Juan Pedro Serna Marmol (Mr.)